PEOPLE - Qiagen makes appointment:
This article was originally published in Clinica
Qiagen in the US has named Donald Schoeny vice-president of commercial operations. Mr Schoeny was previously with PerSeptive BioSystems. Qiagen develops products for the separation, purification and handling of nucleic acids.
You may also be interested in...
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma
The merger between Mylan and Pfizer’s Upjohn unit finally concluded on 16 November 2020, giving Viatris the go ahead for business. The newly-established company has announced receiving tentative approval for its 10mg pediatric dolutegravir tablets from the FDA under the PEPFAR program.
Johnson & Johnson believes personalization via digital holds the key to smoking cessation success as it launches in the UK its app-supported Nicorette QuickMist SmartTrack product.